Femasys announces proposed public offering of common stock and concurrent private placement

Atlanta, may 29, 2025 (globe newswire) -- femasys inc. (nasdaq: femy) (the “company” or “femasys”), a leading biomedical innovator addressing significant unmet needs in women's health worldwide, with a broad portfolio of disruptive, accessible, in-office therapeutic and diagnostic products, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. in addition, femasys expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock sold in the public offering. in addition, certain existing institutional stockholders of femasys and certain of its directors and officers have indicated an interest to purchase shares of common stock in a concurrent private placement.
FEMY Ratings Summary
FEMY Quant Ranking